Search Criteria : United States of America Boston
Jun 02 - 03, 2020 | USD $3650 | Boston, Massachusetts
This Conference has been Cancelled. Accelerating Biotech and Pharmaceutical R&D through Genomics is organized by Harvard Medical School (HMS) and will be held from Jun 02 - 03, 2020 at Harvard Medical School, Boston, Massachusetts, United States of America. Who Should Participate? The program is intended for mid- to senior-level scientific and business leaders who make operational, strategic or investment decisions related to drug discovery and development. It is most appropriate for professionals in the biotech and pharmaceutical industries, or related investing, venture capital and other professional services. Participants from functional areas, including R&D, medical affairs, strategy and business development, can benefit from this program. Typical titles include Director and above. Overview: There has been increasing interest and investment in applying genomics and related technologies to drug discovery and development. However, with the exception of a small number of well-recognized successes, much uncertainty remains about how to best leverage these tools throughout the pharmaceutical value chain. Led by renowned leaders from industry and academia, this executive education program provides a unique opportunity to delve into the use of genomics in common and rare diseases, and throughout the drug discovery, development, regulatory and post-regulatory phases. Pre-work, case-based teaching and group work will ground insights in real-world applications. Topics: This intensive program will feature a combination of pre-work, lectures, panel discussions, case studies and group work. There will be ample time for networking with program faculty and peers. Program topic areas include: • Applications of genetics in common and rare diseases • Discovery and validation of new targets • Moving from genes to function and phenotypes • Identifying causal biomarkers for clinical development • De-risking development by predicting potential adverse effects • Patient segmentation to streamline clinical trials • Strategic approach to companion diagnostics • Regulatory implications of genetics-informed development • Implications for increased use of genetics for patient-centric R&D • Future state: new technologies and approaches Program Objectives: By the end of the program, participants will be able to: • Employ new approaches to leverage genomic tools to validate targets, streamline clinical trials, decrease late development attrition and identify patient groups in the marketplace • Apply program concepts to inform decisions about R&D priorities and directions, evaluation of internal and external opportunities and strategic planning Additional details will be posted as soon as information is available.
Jun 04 - 06, 2020 | CME 34.25 | USD $1495 | Boston, Massachusetts
Treating Obesity 2020: The Blackburn Course in Obesity Medicine is organized by Harvard Medical School (HMS) and will be held from Jun 04 - 06, 2020 at Boston Marriott Long Wharf, Boston, Massachusetts, United States of America. Who Should Attend: Healthcare professionals with an interest in the latest approaches to the prevention and treatment of obesity and its complications, including: • Physicians • Nurse Practitioners • Physician Assistants • Nurses • Pharmacists • Dietitians • Mental Health Professionals Accreditation: • 34.25 AMA PRA Category 1 Credits™ • 34.25 ABIM MOC points and 10.25 patient safety credits • 10.25 Credits of Risk Management Study Participation in both Treating Obesity 2020 and the Obesity Medicine Board Review fully satisfies the 30-hour live Group One CME requirement to qualify for the ABOM certification. Description: Education to Optimize Your Care of Adult, Adolescent, and Pediatric Patients with Obesity This highly rated Harvard Medical School CME course, which has sold out the last 6 years, delivers practical strategies to optimize the management of obesity and its many complications, and provides the most up-to-date approaches to obesity prevention and treatment. Highlights of the 2020 program include: • Comprehensive evaluation of the patient with obesity • Medical management of the patient with obesity • Emerging precision medicine approaches to obesity and metabolic disorders • Optimizing medical outcomes after bariatric surgery • Effective counseling and motivation techniques • Medical and surgical treatment of children and adolescents with obesity • Emerging strategies and therapies for genetic obesity • Navigating our understanding of how diet influences metabolic processes • Building and maintaining a successful Obesity Medicine practice • Enhancing communication about obesity with patients, referring providers, payers, and the public Presented by authorities in medicine, surgery, pediatrics, nutrition, endocrinology, gastroenterology and psychology from the country’s leading obesity treatment centers, this course covers critical topics in the prevention and treatment of obesity and related disorders. In addition, one day prior to the start of Treating Obesity 2020, we host a one-day review for the American Board of Obesity Medicine (ABOM) certification examination. This course is taught by recent diplomates of the ABOM. Treating Obesity 2020 is designed to give healthcare providers the knowledge to: • Identify, evaluate and manage patients with high-risk obesity • Provide lifestyle-based therapies for obesity, including nutritional, physical activity, and behavioral approaches • Apply effective counseling and behavioral modification techniques • Apply current pharmacological approaches to the treatment of obesity • Assess patients for their need and appropriateness for bariatric surgery and determine surgical options
Jun 05 - 06, 2020 | CE Hours 14 | USD $1095 | Boston, Massachusetts
Perio Surgery for the Modern Dental Practice is organized by Perio Institute and will be held from Jun 05 - 06, 2020 at Tufts University School of Dental Medicine, Boston, Massachusetts, United States of America. This Course has been approved for a maximum of 14 CE hours. Description: Join us for an innovative, hands-on course for dentists interested in learning surgical and non-surgical solutions to periodontal disease, including suggested methods for improving patient compliance at home. Participants will take part in hands-on exercises that include flap and suturing, bone contouring, and bone grafting on both pig jaws and anatomically correct models. We will also show an evidenced-based method for the minimally invasive management of moderate to advanced periodontal infection targeting the bacteria and not the pocket. We will explore ongoing maintenance, a key factor for long term success, and emphasize methods that patients can manage at home without being too complicated. With this approach, compliance might be improved over traditional efforts to get people to floss more. In this course, we will clarify diagnosis and treatment planning to help practitioners feel comfortable with different kinds of treatments, and the potential for success of these approaches, whether you treat infective periodontal disease cases yourself or make informed referrals. Topics to be covered include: • Diagnosis • Prognosis • Minimally invasive anti-microbial methods • Instrumentation • Basic flaps and palatal flaps • Osseous concepts for both osseous reduction procedures and basic bone grafting for three wall defects • The role of trauma from the occlusion • Predictable methods for patient motivation that will include a key cornerstone for long term successful maintenance care
Jun 05 - 06, 2020 | CME 11.75 | USD $999 | Boston, Massachusetts
Understanding Global Health Care Delivery is organized by Harvard Medical School (HMS) and will be held from Jun 05 - 06, 2020 at The Inn At Longwood Medical, Boston, Massachusetts, United States of America. Target Audience: This course is targeted to Primary Care Physicians, Specialty Physicians, Nurses, Nurse Practitioners, Pharmacists, Physician Assistants, and Psychologists of all specialties. Accreditation: Physicians: The Harvard Medical School designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Description: It will explore key issues in global health with an emphasis on innovative solutions to provide healthcare to the most vulnerable populations. The course is designed for physicians and healthcare professionals who are interested in learning fundamentals of global health as well as experienced global health practitioners who want to deepen their knowledge. The course will bring together expert faculty from Brigham and Women’s Hospital and Harvard Medical School, many of whom work with Partners In Health, an organization providing health care to rural communities in nine countries. The course will discuss the biosocial determinants of health and disease and explore how programs to deliver healthcare in low-resource settings address these factors. Topics will include the global burden of disease, HIV prevention and treatment, global tuberculosis control, non-communicable disease control, the role of community health workers, global mental health, and global surgery. The course will be taught through lectures and interactive case discussions that seek to provide participants with a rich understanding of the complexities of healthcare delivery in low-resource settings. Objectives: Upon completion of this activity, participants will be able to: • Recognize the global burden of disease and gaps in health care delivery • Explain the social determinants of health and disease • Describe key issues in global health policy • Analyze the design, operations, and outcomes of global health care projects in low-resource settings
Jun 05, 2020 | Boston, Massachusetts
New England Ophthalmological Society (NEOS) Meeting is organized by New England Ophthalmological Society (NEOS) and will be held on Jun 05, 2020 at Back Bay Events Center, Boston, Massachusetts, United States of America. Additional details will be posted as soon as they are available.
Jun 05 - 06, 2020 | Boston, Massachusetts
Advanced Lung Diseases and Transplantation is organized by Harvard Medical School (HMS) and will be held from Jun 05 - 06, 2020 at Boston, Massachusetts, United States of America. Additional details will be posted as soon as information is available.
Jun 06 - 10, 2020 | CME 33.75 | USD $1050 | Boston, Massachusetts
2020 American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting is organized by American Society of Colon and Rectal Surgeons (ASCRS) and will be held from Jun 06 - 10, 2020 at Hynes Convention Center, Boston, Massachusetts, United States of America. Target Audience: The program is intended for the education of colon and rectal surgeons as well as general surgeons and others involved in the treatment of diseases affecting the colon, rectum, and anus. Continuing Medical Education Credit The American Society of Colon and Rectal Surgeons (ASCRS) designates this live activity for a maximum of 33.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Attendees can earn 1 CME Credit hour for every 60 minutes of educational time. Continuing Nursing Education Accreditation SynAptiv is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by California Board of Registered Nursing, Provider #16031 for 33.75 contact hours. Self-Assessment Credit Many of the sessions offered will be designated for self-assessment credit, applicable to Part 2 of the ABCRS MOC program. To claim self-assessment credit, attendees must participate in a post-test. Information/instructions will be sent to all meeting registrants prior to the Annual Meeting. Annual Meeting Scientific Meeting Goals, Purpose and Learning Objectives: The goals of the American Society of Colon and Rectal Surgeons Annual Scientific Meeting are to improve the quality of patient care by maintaining, developing and enhancing the knowledge, skills, professional performance and multidisciplinary relationships necessary for the prevention, diagnosis, and treatment of patients with diseases and disorders affecting the colon, rectum, and anus. The Program Committee is dedicated to meeting these goals. This scientific program is designed to provide surgeons with in-depth and up-to-date knowledge relative to surgery for diseases of the colon, rectum, and anus with emphasis on patient care, teaching, and research. Presentation formats include hands-on workshops, podium presentations followed by audience questions and critiques, panel discussions, ePoster presentations, video presentations and symposia focusing on specific state-of-the-art diagnostic and treatment modalities. The purpose of all sessions is to improve the quality of care of patients with diseases of the colon and rectum. At the conclusion of this meeting, participants should be able to: • Recognize new information in the colon and rectal benign and malignant treatments, including the latest in basic and clinical research. • Describe current concepts in the diagnosis and treatment of diseases of the colon, rectum, and anus. • Apply knowledge gained in all areas of colon and rectal surgery. • Recognize the need for multidisciplinary treatment in patients with diseases of the colon, rectum, and anus.
ITI Education Week Boston Comprehensive Implant Dentistry: From Treatment Plan to Clinical Implementation
Jun 08 - 12, 2020 | CE Hours 33 | Boston, Massachusetts
ITI Education Week Boston Comprehensive Implant Dentistry: From Treatment Plan to Clinical Implementation is organized by International Team for Implantology (ITI) and will be held from Jun 08 - 12, 2020 at Harvard School of Dental Medicine, Boston, Massachusetts, United States of America. This CME Conference has been approved for a maximum of 33 CE hours. Description: This ITI Education Week, held at Harvard University School of Dental Medicine in Boston, has been designed for clinicians with experience in the field of implant dentistry. The program focuses on comprehensive treatment planning in the form of cases that will be presented, discussed and applied on simulation models. This five-day course includes lectures, live surgeries, live prosthetics, workshops and hands-on sessions. It also includes useful translational research information that has a direct impact on clinical applications, underscoring the evidence-based treatment concepts the school applies. Course Details: Lectures: • Current Trends in Implant Treatment Planning • 3D Imaging in Implant Dentistry • Virtual Planning • Guided Implant Placement • Digital Workflow in Implant Prosthodontics • Implant Placement Following Tooth Extraction • Sinus Floor Elevation • Short Implants • Contemporary Materials for Implant Restorations • Implant Loading Protocols • Optimizing Prosthetic Outcomes with Implant Prostheses • Implant Prosthetic Options for Fully Edentulous Patients • Prevention and Treatment of Complications in Implant Dentistry Hands-on workshops: • Digital Treatment Planning • Digital Design of a Surgical Guide • Sinus Floor Elevation • Digital Design and Milling of Implant Restorations • Problem Solving in Implant Dentistry - Interactive Case Discussion Learning Objectives: • Benefit from actively participating in comprehensive implant treatment planning activities • Experience the advantages and challenges of digital workflows in implant dentistry • Plan prosthodontically driven implant placement • Distinguish the indications for immediate, early, and late implant placement • Make evidence-based decisions about implant loading times • Understand indications for sinus floor elevation and approaches vs. the use of short implants • Discuss implant and implant prosthodontics complications, their prevention and treatment
Jun 08 - 11, 2020 | CME 30 | USD $1445 | Boston, Massachusetts
This conference has been CANCELLED. Gastroenterology 2020 is organized by Harvard Medical School (HMS) and will be held from Jun 08 - 11, 2020 at Fairmont Copley Plaza, Boston, Massachusetts, United States of America. Who Should Attend: • Gastroenterologists • Internists • Surgeons • Nurse Practitioners • Physician Assistants Accreditation: • 30.00 AMA PRA Category 1 Credits™ • 30.00 ABIM MOC points Course Description: The Comprehensive 2020 Gastroenterology Update This Harvard Medical School CME program, which sold out the last three years, ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians. Gastroenterology 2020 provides a comprehensive update for clinicians who care for patients with GI disorders. It covers state-of-the-art clinical strategies, updates and expanded options for treatment and diagnosis, and guidance for complex and unusual cases. This program is led by the nationally and internationally recognized GI leaders at Harvard Medical School and its major teaching hospitals: Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, and Massachusetts General Hospital. Learners leave this program with comprehensive updates and evidence-based approaches from master clinicians. Education is results focused, incorporating cases and guidance that show participants how to achieve improved clinical and quality-of-life outcomes for patients with GI disorders. The field of gastroenterology is continually evolving, and this impacts many different areas of our practice. New conditions such as GI complications from immunotherapy have emerged, and new biologic therapies for IBD reach the market regularly. In the endoscopic arena, there are many exciting developments to enhance polyp detection and resection, to control bleeding, and to ablate Barrett’s esophagus. Scientific advances have also brought provocative new approaches such as fecal transplant into our therapeutic armamentarium. As gastroenterologists, we are entrusted to manage an incredibly broad array of disorders that span the gastrointestinal, hepatic, and pancreaticobiliary systems. Our goal is to ensure that you are up to date with the current approaches for the diagnosis and management of these disorders so that you are prepared to provide the best care for your patients. Importantly, our talented faculty is highly responsive to you, and we consider it a priority to take the time to address individual questions you may have. Practical, Results-Driven Education Highlights of the 2020 program include: • Updated guidelines for the use of biologics in IBD • Therapeutic drug monitoring in IBD treatment • Managing GI complications of immunotherapy • Improved management of IBS, pelvic floor disorders, and functional dyspepsia • Expanded options to diagnose hereditary GI cancer syndromes • Management of fatty liver disease in 2020 • Best practices for treatment of HBV and HCV • How to improve your adenoma detection rate (ADR) • Steps to ensure delivery of high-quality endoscopic care • Techniques to effectively control GI bleeding • When FMT is indicated for treatment • New strategies to treat common GI problems • Guidance to diagnose and treat complex cases • A comprehensive update of national guidelines As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work. Education to Optimize Your Patient Outcomes The evidence-based recommendations provided in this program cover: • IBD • GI Complications of Immunotherapy • Microscopic Colitis • Hepatitis B and C • Fatty Liver • Barrett’s Esophagus • Eosinophilic Esophagitis • C. difficile Colitis • Refractory GERD • IBS • Acute Pancreatitis • Chronic Pancreatitis • Celiac Disease • GI Bleeding • Colorectal Cancer Screening • Nutritional Management in GI Disorders Recent Advances and Innovations Clinicians can rely on this program for education on: • Biological therapies for IBD: How to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available? • Managing refractory pouchitis • GI complications of immunotherapy — a common and heterogeneous disorder: How to approach and treat effectively? • Antiviral therapies for hepatitis B and C: How to select which regimen to use? Understanding long-term risks of therapy • Eosinophilic esophagitis: How to decide between drug therapy and dietary therapy? • The stool microbiome: Understanding the science behind clinical applications • Celiac disease: Making sense of the multiple serologic tests—new therapeutic strategies are on the horizon • Adenoma detection rates: Critical to measure and how to incorporate strategies to increase your rate This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics. Learning Objectives: Upon completion of this activity, participants will be able to: • Interpret major advances in the field of gastroenterology • Incorporate the most up-to-date diagnostic approaches to GI disorders • Identify therapeutic options for GI disorders in an evidence-based manner • Manage patients with both common and rare GI disorders using established guidelines
Jun 13 - 14, 2020 | Boston, Massachusetts
This Conference has been Cancelled. Intensive Review of Emergency Radiology is organized by Harvard Medical School (HMS) and will be held from Jun 13 - 14, 2020 at Richard B. Simches Research Conference Center, Boston, Massachusetts, United States of America. Additional details will be posted as soon as information is available.